Get the latest Science News and Discoveries

The FDA Just Rejected a Bid for MDMA to Treat PTSD


The regulatory agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder.

None

Get the Android app

Or read this on Wired.com

Read more on:

Photo of approval

approval

Photo of bid

bid

Photo of MDMA

MDMA

Related news:

News photo

FDA approves drug targeting Johns Hopkins-discovered brain cancer gene mutation - EurekAlert

News photo

Veterans and Lawmakers Lobby for Approval of MDMA Therapy

News photo

Breakthrough in bid to develop vaccines and drugs for neglected tropical disease